Monday, June 9, 2014

Killing two birds with one anti-viral stone

Click to visit the Hepatitis B Foundation
CANCER DIGEST – June 9, 2014 – An anti-viral treatment for hepatitis B may turn out to prevent liver cancer according to a new study of 2600 patients treated for the disease. In a first-of-its-kind analysis those treated with antiviral therapy had a significantly lower occurrence of liver cancer during a five-year follow up period. Overall, 3 percent of the patients developed liver cancer during the study period. But patients who received antiviral therapy were 60 percent less likely to develop liver cancer than untreated patients. “The results of this study allow us to reassure our patients that we are not just treating their viral levels, but that antiviral therapy may actually lessen their chance of developing liver cancer,” said the study’s lead investigator, Henry Ford Health System’s Stuart C. Gordon, M.D. The finding was published in the May issue of Clinical Gastroenterology and Hepatology.

No comments:

Post a Comment